JPH03169841A - アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法 - Google Patents

アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法

Info

Publication number
JPH03169841A
JPH03169841A JP2222696A JP22269690A JPH03169841A JP H03169841 A JPH03169841 A JP H03169841A JP 2222696 A JP2222696 A JP 2222696A JP 22269690 A JP22269690 A JP 22269690A JP H03169841 A JPH03169841 A JP H03169841A
Authority
JP
Japan
Prior art keywords
formula
group
general formula
producing
aminopropanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2222696A
Other languages
English (en)
Japanese (ja)
Inventor
Zoltan Budai
ゾルターン　ブダイ
Tibor Mezei
ティボル　メゼイ
Lujza Petoecz
ルイザ　ペテーツ
Szecsey Maria
マーリア　セーチェイ
Marton Fekete
フェケテ マールトン
Nee Fekete Hoffmann Valeria
ヴァレーリア　ホフマン　ネーエ　フェケテ
Nee Esses Klara Reiter
クラーラ　レイテル　ネーエ　エシェッシュ
Nee Kiszelly Enikoe Szirt
エニコェー　シルト　ネーエ　キセリ
Gizella Zsila
ギゼルラ　ジラ
Gabor Gigler
ギグレル ガーボル
Laszlo Kapolnai
ラースロー　カーポルナイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of JPH03169841A publication Critical patent/JPH03169841A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/20—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups being part of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
JP2222696A 1989-08-25 1990-08-27 アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法 Pending JPH03169841A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU4401/89 1989-08-25
HU894401A HU212415B (en) 1989-08-25 1989-08-25 Process for producing new cyclic oxym derivatives and pharmaceutical compositions containing them as active components

Publications (1)

Publication Number Publication Date
JPH03169841A true JPH03169841A (ja) 1991-07-23

Family

ID=10967860

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2222696A Pending JPH03169841A (ja) 1989-08-25 1990-08-27 アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法

Country Status (24)

Country Link
US (1) US5130487A (en, 2012)
JP (1) JPH03169841A (en, 2012)
KR (1) KR910004547A (en, 2012)
AT (1) AT399504B (en, 2012)
BE (1) BE1004530A3 (en, 2012)
BG (1) BG92749A (en, 2012)
CA (1) CA2023957A1 (en, 2012)
CH (1) CH681369A5 (en, 2012)
DD (1) DD297402A5 (en, 2012)
DE (1) DE4027052A1 (en, 2012)
DK (1) DK203290A (en, 2012)
ES (1) ES2021261A6 (en, 2012)
FI (1) FI904191A7 (en, 2012)
FR (1) FR2651227B1 (en, 2012)
GB (1) GB2235198B (en, 2012)
GR (1) GR1000740B (en, 2012)
HU (1) HU212415B (en, 2012)
IT (1) IT1243203B (en, 2012)
NL (1) NL9001865A (en, 2012)
PL (1) PL163028B1 (en, 2012)
RU (1) RU2066310C1 (en, 2012)
SE (1) SE9002727L (en, 2012)
YU (1) YU48372B (en, 2012)
ZA (1) ZA906744B (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212262B (en) * 1992-10-30 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process to prepare benz /e/ indene derivs. and the pharmaceutical compns. contg. them
HUT67314A (en) * 1993-04-09 1995-03-28 Egyt Gyogyszervegyeszeti Gyar Process for prepg. new trisubstituted cykloalkane deriv.s and pharmaceutical compn.s contg. them
HU213421B (en) * 1993-04-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar New basic ethers, pharmaceutical compns. containing the said compds. and process for prepg. them
HU213472B (en) * 1993-07-20 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process to preparare pharmaceutical compns. with gastroprotective and anti helicobacter pylori activity
US5597822A (en) * 1993-07-20 1997-01-28 Egis Pharmaceutical Pharmaceutical compositions for the prevention and/or treatment a gastrointestinal diseases
DE19722848A1 (de) * 1997-05-23 1998-11-26 Schering Ag Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten
KR20080035702A (ko) 2002-01-11 2008-04-23 상꾜 가부시키가이샤 아미노 알코올 유도체 또는 포스폰산 유도체 및 이들을함유하는 의약 조성물
CN1921847B (zh) 2004-02-24 2010-06-16 三共株式会社 氨基醇化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
GB1493222A (en) * 1976-01-27 1977-11-30 Egyt Gyogyszervegyeszeti Gyar Cycloalkanone oxime ethers and process for the preparation thereof
AT339276B (de) * 1976-01-27 1977-10-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur herstellung von basischen cycloalkanonoximathern und deren saureadditionssalzen
DE2658938A1 (de) * 1976-12-24 1978-07-06 Hoechst Ag Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4652586A (en) * 1980-11-07 1987-03-24 The General Hospital Corporation Selective beta-2 adrenergic antagonists for the treatment of glaucoma
FR2521856A1 (fr) * 1982-02-19 1983-08-26 Pos Lab Medicament ophtalmique pour le traitement des glaucomes, a base d'ethers-oxydes ou d'ether-oximes de derives alcoylamines
HU189226B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing basic oxime-ethers
HU189227B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing basic oxime-ethers
HU197205B (en) * 1984-07-10 1989-03-28 Egyt Gyogyszervegyeszeti Gyar Process for production of medical compositions against angine
US4803286A (en) * 1987-08-19 1989-02-07 Merck & Co., Inc. Amino-2-hydroxypropyloximinoheterocycle α-blockers

Also Published As

Publication number Publication date
KR910004547A (ko) 1991-03-28
IT9021305A0 (it) 1990-08-24
GR1000740B (el) 1992-12-30
PL163028B1 (pl) 1994-02-28
AT399504B (de) 1995-05-26
GB2235198A (en) 1991-02-27
GB9018583D0 (en) 1990-10-10
DK203290A (da) 1991-02-26
ZA906744B (en) 1991-06-26
PL286613A1 (en) 1991-05-06
HU212415B (en) 1996-06-28
DK203290D0 (da) 1990-08-24
HUT58282A (en) 1992-02-28
GB2235198B (en) 1993-06-02
FI904191A0 (fi) 1990-08-24
DE4027052C2 (en, 2012) 1993-09-09
IT1243203B (it) 1994-05-24
SE9002727L (sv) 1991-02-26
IT9021305A1 (it) 1992-02-24
FI904191A7 (fi) 1991-02-26
CH681369A5 (en, 2012) 1993-03-15
GR900100627A (en) 1991-12-30
YU160990A (sh) 1992-12-21
YU48372B (sh) 1998-07-10
FR2651227A1 (fr) 1991-03-01
NL9001865A (nl) 1991-03-18
DE4027052A1 (de) 1991-03-07
DD297402A5 (de) 1992-01-09
CA2023957A1 (en) 1991-02-26
RU2066310C1 (ru) 1996-09-10
FR2651227B1 (fr) 1992-07-31
BG92749A (bg) 1993-12-24
ES2021261A6 (es) 1991-10-16
SE9002727D0 (sv) 1990-08-24
ATA174290A (de) 1994-10-15
US5130487A (en) 1992-07-14
BE1004530A3 (fr) 1992-12-08

Similar Documents

Publication Publication Date Title
AU2006242950B2 (en) Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3 -receptor ligands
AU2005265769A1 (en) 5-substituted-2-phenylamino-benzamides as MEK inhibitors
HU197293B (en) Process for producing new phenoxy-acetamide derivatives and pharmaceutical compositions containing them as active components
JP2637737B2 (ja) 新規な薬剤
JPS5920275A (ja) ピペラジン誘導体、その製造法並びにこれらを含有する薬剤処方物
AU2004209020A2 (en) New arylpiperazinyl compounds
JPH03169841A (ja) アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法
EP1259492A1 (de) Substituierte piperazinderivate als inhibitoren des mtp
US4880841A (en) Process of producing phenethylamine derivatives
FR2460294A1 (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
HK1042092A1 (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
US5234934A (en) Aminopropanol derivatives, process for their preparation and pharmaceutical compositions comprising the same
JP3786983B2 (ja) ピロリジノン誘導体
EP0110253B1 (de) Substituierte 1-Oxo-2-phenyl-2-(2-alkylaminoethyl)-1,2,3,4-tetrahydronaphthaline, ihre Herstellung und Verwendung
JPH01104064A (ja) 塩基性に置換されたベンゾフランカルボン酸アミド、この化合物の製法及びこれを含有する医薬
JPH0336836B2 (en, 2012)
US3903165A (en) Ethynylaryl amines and processes for their preparation
EP0575361B1 (de) Neue 1-aryl-4-piperazinyl-cyclohexancarbonsäurenitrile, ihre herstellung und verwendung
WO2000009501A1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
DD157796A5 (de) Verfahren zur herstellung neuer derivate des 2-amino-aethanols
US4271161A (en) Indane-acetic acid aminoesters, their preparation and their use in therapy
JPS5839832B2 (ja) 新規ピラジン化合物の製法
HU211858A9 (hu) Új aminopropanolszármazékok, eljárás ezek előállítására és ilyen hatóanyagot tartalmazó gyógyszerkészítmények
JPS63174978A (ja) 新規なアミノアルカイノイルージベンゾ−ｄ，ｇ−１，３，６−ジオキサゾシン及びその製法
IL95465A (en) Derivatives of aminopropanol, the process for their preparation and pharmaceutical preparations containing them